CARDIOGENIC SHOCK
Clinical trials for CARDIOGENIC SHOCK explained in plain language.
Never miss a new study
Get alerted when new CARDIOGENIC SHOCK trials appear
Sign up with your email to follow new studies for CARDIOGENIC SHOCK, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Heart shock study tests aggressive pump escalation
Disease control OngoingThis study looks at people having a severe heart attack complicated by cardiogenic shock, where the heart can't pump enough blood. Doctors are testing whether quickly increasing the level of mechanical pump support (called MCS) can help more patients survive to leave the hospital…
Matched conditions: CARDIOGENIC SHOCK
Sponsor: Henry Ford Health System • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
Heart shock drug shows promise in reducing deaths
Disease control OngoingThis study tests if giving empagliflozin early to people with cardiogenic shock (a severe heart pump failure) can lower the chance of death or repeat hospital visits for heart failure within 3 months. Researchers looked back at records of 418 adults treated in intensive care. The…
Matched conditions: CARDIOGENIC SHOCK
Sponsor: Central Hospital, Nancy, France • Aim: Disease control
Last updated May 06, 2026 16:15 UTC
-
Heart pump data study aims to sharpen shock treatment
Knowledge-focused OngoingThis study gathers detailed, real-time information from the Impella heart pump and standard monitors in 125 people with cardiogenic shock. The goal is to better understand how the pump and body work together, not to test a new treatment. Participants are already using the Impella…
Matched conditions: CARDIOGENIC SHOCK
Sponsor: Abiomed Inc. • Aim: Knowledge-focused
Last updated May 17, 2026 06:46 UTC